rTMS in Aphasic Patients With Neuroimage Assessments

Sponsor
Taipei Veterans General Hospital, Taiwan (Other)
Overall Status
Recruiting
CT.gov ID
NCT03059225
Collaborator
(none)
120
1
3
58.1
2.1

Study Details

Study Description

Brief Summary

The refinement of repetitive transcranial magnetic stimulation (rTMS) has highlighted its merit in terms of learning programs as a treatment for aftereffect augmentation. Nevertheless, the efficacy of synchronous rTMS protocol integrated with computer-integrated speech training is not well understood. It is also not clear regarding the efficacy of compound bi-hemispheric stimulation protocol. The aim of the study is to investigate language response to these new strategies and to determine the longevity of the therapeutic outcome. Advanced MR neuroimaging techniques, such as fMRI and DTI, are powerful tools to evaluate the concomitant nervous changes after rTMS treatment on aphasic patients. The knowledge from fMRI and DTI microstructural evolution provides insight into underlined mechanism operating the language improvement.

Condition or Disease Intervention/Treatment Phase
  • Device: repetitive transcranial magnetic stimulation (rTMS)
  • Device: Sham stimulation
N/A

Detailed Description

The efficacy of synchronous rTMS protocol integrated with computer-integrated speech training is not well understood. It is also not clear regarding the efficacy of inhibitory or excitatory stimulation protocol. The aim of the study is to investigate language response to these new strategies and to determine the longevity of the therapeutic outcome. Advanced MR neuroimaging techniques, such as fMRI and DTI, are powerful tools to evaluate the concomitant nervous changes after rTMS treatment on aphasic patients. The knowledge from fMRI and DTI microstructural evolution provides insight into underlined mechanism operating the language improvement

Study Design

Study Type:
Interventional
Anticipated Enrollment :
120 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Triple (Participant, Investigator, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Synchronous rTMS and Computer-integrated Speech Training Applied in Aphasic Patients
Actual Study Start Date :
Feb 18, 2017
Anticipated Primary Completion Date :
Dec 23, 2021
Anticipated Study Completion Date :
Dec 23, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: Experimental

repetitive transcranial magnetic stimulation (rTMS) intervention of contralesional 1Hz-rTMS for 10 daily sessions.

Device: repetitive transcranial magnetic stimulation (rTMS)
undergo contralesional 1Hz repetitive transcranial magnetic stimulation(rTMS) or high frequency ipsilesional rTMS for 10 daily sessions

Sham Comparator: Sham stimulation

Sham treatment for 2-week inhibitory non-dominate hemisphere rTMS program.

Device: Sham stimulation
2-week inhibitory non-dominate hemisphere rTMS program

Experimental: High frequency rTMS

High-frequency rTMS to ipsilesional region for 10 daily sessions.

Device: repetitive transcranial magnetic stimulation (rTMS)
undergo contralesional 1Hz repetitive transcranial magnetic stimulation(rTMS) or high frequency ipsilesional rTMS for 10 daily sessions

Outcome Measures

Primary Outcome Measures

  1. Change From Baseline in aphasia level on the Concise Chinese Aphasia Test (CCAT) at 2 Weeks [Up to 12 weeks]

    linguistic function assessment

Secondary Outcome Measures

  1. Change from Baseline in the concomitant nervous status on the Functional magnetic resonance imaging (fMRI) at 2 weeks [Up to 12 weeks]

    brain activity change in fMRI

Eligibility Criteria

Criteria

Ages Eligible for Study:
30 Years to 85 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Aphasic stroke in chronic stage (over 3 months)
Exclusion Criteria:
  • No seizure history, no brain surgery history, no electronic device in brain or chest, no dementia

Contacts and Locations

Locations

Site City State Country Postal Code
1 Taipei Veterans General Hospital Taipei Taiwan

Sponsors and Collaborators

  • Taipei Veterans General Hospital, Taiwan

Investigators

  • Principal Investigator: Po-Yi Tsai, MD, Department of physical medicine and rehabilitation, Taipei Veterans General Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
vghtpe user, Principal investigator, Taipei Veterans General Hospital, Taiwan
ClinicalTrials.gov Identifier:
NCT03059225
Other Study ID Numbers:
  • 2014-05-003A
First Posted:
Feb 23, 2017
Last Update Posted:
Jan 8, 2021
Last Verified:
Jan 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by vghtpe user, Principal investigator, Taipei Veterans General Hospital, Taiwan
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 8, 2021